Vangard Recombishield Injectable Bordetella Vaccine 50 Dose (50 x 1 mL vials)

Zoetis Vanguard Recombishield Bordetella Injectable 50×1 offers veterinarians and animal care professionals an innovative injectable option for Bordetella vaccination in dogs. Designed for situations where oral or intranasal vaccines may not be suitable, Recombishield helps provide effective protection while simplifying vaccine administration for head-shy or immunocompromised dogs. As the first and only canine Bordetella vaccine featuring recombinant pertactin protein technology, Recombishield is formulated to help support a strong and optimized immune response. The advanced recombinant-made formulation is designed to provide effective immunological support without the use of adjuvants. The nonadjuvanted formula helps minimize discomfort during administration, including reduced pain, swelling, vocalization, and injection-site reactivity compared to some traditional vaccine options. This makes Recombishield a practical choice for dogs that may experience stress or difficulty with intranasal administration methods. Packaged in a convenient 50-dose format, this injectable Bordetella vaccine is ideal for veterinary clinics, shelters, breeders, boarding facilities, and animal care professionals seeking reliable canine respiratory protection solutions. Features & Benefits: Injectable Bordetella vaccine for dogs Alternative option to oral or intranasal Bordetella vaccines Designed for head-shy and immunocompromised dogs Recombinant-made vaccine technology Contains pertactin protein for optimized immune response Nonadjuvanted formula Helps minimize pain, swelling, and injection-site reactivity Helps reduce discomfort and vocalization during administration Simplifies vaccine administration Convenient 50-dose package for veterinary use Ideal For: Veterinary clinics and hospitals Boarding and kennel facilities Head-shy dogs Immunocompromised dogs Canine respiratory vaccination protocols